Pliant Therapeutics, Inc. (PLRX)

NASDAQ: PLRX · IEX Real-Time Price · USD

12.36

-0.09 (-0.72%)

At close: Jul 19, 2024, 4:00 PM

12.35

-0.01 (-0.08%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Pliant Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-170.74	-161.34	-123.32	-97.26	-41.53	-6.86	Upgrade
Depreciation & Amortization	4.36	4.23	3.68	3.2	1.31	1.11	Upgrade
Share-Based Compensation	42.23	44.48	22.6	10.44	3.9	1.83	Upgrade
Other Operating Activities	7.8	-3.74	2.41	8.18	-0.94	-5.06	Upgrade
Operating Cash Flow	-116.36	-116.36	-94.63	-75.44	-37.27	-2.75	Upgrade
Capital Expenditures	-2.25	-0.92	-1.76	-1.95	-1.53	-0.96	Upgrade
Change in Investments	108.99	-126.09	-148.44	75.65	-209.33	-16.71	Upgrade
Other Investing Activities	-	-	-	-	-	-0.25	Upgrade
Investing Cash Flow	106.74	-127.01	-150.2	73.7	-210.87	-17.93	Upgrade
Share Issuance / Repurchase	3.22	275.25	217.56	2.98	161.19	0.17	Upgrade
Debt Issued / Paid	19.91	0	9.85	0	0	0	Upgrade
Other Financing Activities	-0.26	-0.85	-0.56	-0.46	52.02	45.37	Upgrade
Financing Cash Flow	22.87	274.41	226.85	2.53	213.21	45.54	Upgrade
Net Cash Flow	13.25	31.03	-17.98	0.78	-34.93	24.86	Upgrade
Free Cash Flow	-118.61	-117.28	-96.39	-77.4	-38.8	-3.71	Upgrade
Free Cash Flow Margin	-47825.00%	-7422.91%	-995.26%	-1022.13%	-92.79%	-6.51%	Upgrade
Free Cash Flow Per Share	-1.97	-2.00	-2.29	-2.16	-1.82	-2.29	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).